BMEA earnings: real EPS beat/miss history, analyst consensus Buy, P/E -1.46. Updated 2026-07-23.
Biomea Fusion (BMEA) Research Hub
Biomea Fusion (BMEA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 1.74 USD (-5.95%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.46, market cap 0.08B. This hub links to the full technical, earnings and options research available for BMEA.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.74 USD (-5.95%) |
| 52-week range | 1.16 USD – 2.07 USD |
| Trend regime | Range |
| 14-day RSI | 70.7 (Overbought) |
| Trailing P/E | -1.46 |
| Market cap | 0.08B |
| Dividend yield | 0.00% |
Available research for BMEA
Covered Call on BMEA: how it works, illustrative setup around the real 1.74 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BMEA: how it works, illustrative setup around the real 1.74 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BMEA: how it works, illustrative setup around the real 1.74 USD price, max profit/loss, breakeven and when to use it. Educational.
BMEA technical analysis: range, last 1.74 USD, RSI 70.7, 52w range 1.16 USD–2.07 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is BMEA in?
Biomea Fusion (BMEA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is BMEA in an uptrend or downtrend?
As of 2026-09-11, BMEA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BMEA's trailing P/E ratio?
BMEA's trailing P/E is -1.46, with a market cap of 0.08B. See the earnings research page for full valuation detail.